These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 5785067)

  • 41. Dynamics of antitumor resistance after cyclophosphamide injection.
    Terpinskaya TI
    Bull Exp Biol Med; 2012 Mar; 152(5):613-4. PubMed ID: 22803147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic activity of pretazettine on Ehrlich ascites carcinoma: adjuvant effect on standard drugs in ABC regimen.
    Furusawa E; Lum MK; Furusawa S
    Chemotherapy; 1981; 27(4):277-86. PubMed ID: 7249790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of some fatty acid esters on the viability and transplantability of Ehrlich ascites tumor cells.
    Kato A; Ando K; Tamura G; Arima K
    Cancer Res; 1971 May; 31(5):501-4. PubMed ID: 5582112
    [No Abstract]   [Full Text] [Related]  

  • 44. Substances with antineoplastic activity. 28. Cytostatic and pharmacologic properties of beta-4-methoxybenzoyl-beta-bromacrylic acid sodium salt.
    Jelínek V; Semonský M; Francová V; Veselá H; Hradil F
    Neoplasma; 1969; 16(2):121-31. PubMed ID: 4308999
    [No Abstract]   [Full Text] [Related]  

  • 45. Cytogenetic changes induced by 1-(N1-methylhydrazinomethyl)-N-isopropyl benzamide in Ehrlich ascites tumor cells.
    Huang AT; Gutterman J; Hochstein P
    Experientia; 1969 Feb; 25(2):203-4. PubMed ID: 5786111
    [No Abstract]   [Full Text] [Related]  

  • 46. [Antitumor effect of natural avermectins].
    Driniaev VA; Mosin VA; Krugliak EB; Sterlina TS; Novik TS; Ermakova NV; Kublik LN; Levitman MKh; Shaposhnikova VV; Korystov IuN
    Antibiot Khimioter; 2004; 49(5):8-10. PubMed ID: 15573897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antineoplastic action of methylglyoxal.
    Jerzykowski T; Matuszewski W; Otrzonsek N; Winter R
    Neoplasma; 1970; 17(1):25-35. PubMed ID: 4315796
    [No Abstract]   [Full Text] [Related]  

  • 48. Inhibitory effect of hydroxynitrodihydrothymine on the growth of Ehrlich ascites tumor cells.
    Mustea I; Bara A; Comes R; Postescu ID
    Cancer Treat Rep; 1978 May; 62(5):823-7. PubMed ID: 26466
    [No Abstract]   [Full Text] [Related]  

  • 49. [Studies on the radiation sensitizing effect of 6-anaurazilribosid depending on the irradiation time in the Ehrlich tumor].
    Magdon E; Konopatzky R; Sterescu M
    Strahlentherapie; 1968 Aug; 136(2):237-40. PubMed ID: 5695894
    [No Abstract]   [Full Text] [Related]  

  • 50. [Resistance to colchicine in a glycogen-containing subline of the Ehrlich-Lettré-ascites-tumour].
    Granzow C; Ehe-Galster U
    Z Krebsforsch; 1970; 74(4):329-37. PubMed ID: 4253580
    [No Abstract]   [Full Text] [Related]  

  • 51. Antitumor organometallics. II. Inhibitory effects of two diphenyl-antimony (III) dithiophosphorus derivatives on in vitro and in vivo Ehrlich ascites tumor.
    Socaciu C; Bara A; Silvestru C; Haiduc I
    In Vivo; 1991; 5(4):425-8. PubMed ID: 1667268
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of various antitumor agents on intracerebrally inoculated Ehrlich ascites carcinoma in mice (author's transl)].
    Zhou JX; He GH; Tao LX; Xu B
    Zhongguo Yao Li Xue Bao; 1981 Dec; 2(4):256-61. PubMed ID: 6462026
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of 1, 3-diallylurea and related compounds on growth of transplanted animal tumors.
    Tarnowski GS; Cappuccino JG; Schmid FA
    Cancer Res; 1967 Jun; 27(6):1092-5. PubMed ID: 5229785
    [No Abstract]   [Full Text] [Related]  

  • 54. Relation between antitumor activity and chemical structure in some derivatives of 2-amino-6-purinethiol.
    Fukuoka F; Tokuzen R; Hoshi A; Egami F; Nagasawa K
    Gan; 1969 Apr; 60(2):187-97. PubMed ID: 5810964
    [No Abstract]   [Full Text] [Related]  

  • 55. Digoxin is a selective modifier increasing platinum drug anticancer activity.
    Bogush TA; Chernov VY; Dudko EA; Shprakh ZS; Bogush EA; Polotsky BE; Tjulandin SA; Davydov MI
    Dokl Biochem Biophys; 2016 May; 468(1):220-3. PubMed ID: 27417726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antitumor effect of synthetic cord factor analogue, 6, 6'-Di-O-decanoyl-alpha, alpha-trehalose].
    Ishii F; Takano S; Kohya H; Ishida N
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1629-34. PubMed ID: 6548105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antitumor properties of boron complexes with hydroxy biguanide and salicyl hydroxamic acid against Ehrlich ascites carcinoma.
    Ghosh P; Bag SP; Sur B; Sur P
    Neoplasma; 1998; 45(2):68-72. PubMed ID: 9687884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Experimental study of the antineoplastic effect of triprotamin isolated from the milt of sturgeons].
    Pasternak NA; Shenderovich VA; Ermol'eva ZV
    Antibiotiki; 1971; 16(8):704-7. PubMed ID: 5139446
    [No Abstract]   [Full Text] [Related]  

  • 59. [Autoradiography studies of cell proliferation and the effect of cytostatic agents on the proliferation of normal and tumor cells].
    Maurer-Schultze B
    Acta Histochem Suppl; 1983; 27():9-30. PubMed ID: 6191361
    [No Abstract]   [Full Text] [Related]  

  • 60. [Influencing the mitosis rate of the Ehrlich ascites carcinoma in the white mouse with serotonin].
    Seipelt H; Iwanoff S
    Z Gesamte Exp Med Einschl Exp Chir; 1965; 139(5):433-7. PubMed ID: 5859471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.